| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 9.10e-05 | 10 | 29 | 2 | GO:0009931 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 6.99e-04 | 27 | 29 | 2 | GO:0004683 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 1.18e-03 | 35 | 29 | 2 | GO:0051019 | |
| GeneOntologyMolecularFunction | transporter activity | 2.04e-03 | 1289 | 29 | 7 | GO:0005215 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 3.60e-04 | 1293 | 30 | 8 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 3.72e-04 | 1299 | 30 | 8 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 4.29e-04 | 1327 | 30 | 8 | GO:0042175 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 1.15e-03 | 35 | 30 | 2 | GO:0098553 | |
| Domain | MAPKAPK_C | 6.50e-06 | 3 | 28 | 2 | IPR027442 | |
| Domain | - | 6.50e-06 | 3 | 28 | 2 | 4.10.1170.10 | |
| Domain | Lung_7-TM_R | 1.30e-05 | 4 | 28 | 2 | PF06814 | |
| Domain | GPR107-like | 1.30e-05 | 4 | 28 | 2 | IPR009637 | |
| Domain | GPCR_2-like | 3.64e-03 | 60 | 28 | 2 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.76e-03 | 61 | 28 | 2 | PS50261 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 4.78e-03 | 69 | 28 | 2 | IPR020636 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 5.32e-05 | 7 | 23 | 2 | MM14672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST | 1.39e-04 | 11 | 23 | 2 | M47614 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.66e-04 | 12 | 23 | 2 | MM14657 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 1.96e-04 | 13 | 23 | 2 | M1441 | |
| Pathway | BIOCARTA_HSP27_PATHWAY | 2.29e-04 | 14 | 23 | 2 | M2587 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 4.75e-04 | 20 | 23 | 2 | M12256 | |
| Pathway | PID_P38_MK2_PATHWAY | 5.25e-04 | 21 | 23 | 2 | M199 | |
| Pathway | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | 6.31e-04 | 23 | 23 | 2 | M17243 | |
| Pathway | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | 6.88e-04 | 24 | 23 | 2 | MM15133 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 8.08e-04 | 26 | 23 | 2 | MM14716 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 1.38e-03 | 34 | 23 | 2 | M13881 | |
| Pathway | WP_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION | 1.55e-03 | 36 | 23 | 2 | MM15967 | |
| Pathway | REACTOME_MATURATION_OF_SPIKE_PROTEIN | 1.64e-03 | 37 | 23 | 2 | M41728 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 1.64e-03 | 37 | 23 | 2 | MM14899 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 1.64e-03 | 37 | 23 | 2 | M42558 | |
| Pathway | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | 1.73e-03 | 38 | 23 | 2 | M229 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 1.96e-03 | 155 | 23 | 3 | MM14665 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 29187369 | ||
| Pubmed | Post-Golgi anterograde transport requires GARP-dependent endosome-to-TGN retrograde transport. | 6.71e-07 | 2 | 29 | 2 | 26157166 | |
| Pubmed | Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis. | 6.71e-07 | 2 | 29 | 2 | 23372691 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 27694493 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 31167133 | ||
| Pubmed | Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity. | 6.71e-07 | 2 | 29 | 2 | 24082115 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 24935968 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25792706 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 23608535 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 10781029 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 26068544 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 8774846 | ||
| Pubmed | p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins. | 2.01e-06 | 3 | 29 | 2 | 20724476 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 7799959 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 21586572 | ||
| Pubmed | Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. | 2.01e-06 | 3 | 29 | 2 | 8846784 | |
| Pubmed | The MK2/3 cascade regulates AMPAR trafficking and cognitive flexibility. | 2.01e-06 | 3 | 29 | 2 | 25134715 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 3.04e-06 | 499 | 29 | 6 | 22810586 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 33427298 | ||
| Pubmed | Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. | 4.02e-06 | 4 | 29 | 2 | 28011639 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 11335727 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 21575178 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 31334837 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.44e-06 | 1201 | 29 | 8 | 35696571 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 14578350 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 28920954 | ||
| Pubmed | The Role of TTP Phosphorylation in the Regulation of Inflammatory Cytokine Production by MK2/3. | 6.70e-06 | 5 | 29 | 2 | 31527197 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 20484669 | ||
| Pubmed | Structure of the GOLD-domain seven-transmembrane helix protein family member TMEM87A. | 6.70e-06 | 5 | 29 | 2 | 36373655 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 17906627 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 17030606 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 25693418 | ||
| Pubmed | 1.29e-05 | 371 | 29 | 5 | 25241761 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 32424229 | ||
| Pubmed | MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells. | 1.87e-05 | 8 | 29 | 2 | 19369945 | |
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 29229781 | ||
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 15850461 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 12171600 | ||
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 4.41e-05 | 12 | 29 | 2 | 9297626 | |
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 11318611 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 2.07e-04 | 1061 | 29 | 6 | 33845483 | |
| Pubmed | Nerve growth factor signaling, neuroprotection, and neural repair. | 2.15e-04 | 26 | 29 | 2 | 11520933 | |
| Pubmed | 4.09e-04 | 174 | 29 | 3 | 32149426 | ||
| Pubmed | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. | 4.39e-04 | 37 | 29 | 2 | 24162737 | |
| Pubmed | 4.59e-04 | 438 | 29 | 4 | 32628020 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 5.89e-04 | 468 | 29 | 4 | 31056421 | |
| Pubmed | Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview | 6.21e-04 | 44 | 29 | 2 | 20301507 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 2.65e-04 | 191 | 30 | 3 | chr11q24 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 7.72e-05 | 11 | 22 | 2 | 1156 | |
| GeneFamily | Olfactory receptors, family 4 | 1.06e-02 | 129 | 22 | 2 | 151 | |
| GeneFamily | Solute carriers | 1.17e-02 | 395 | 22 | 3 | 752 | |
| Coexpression | GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 2.52e-06 | 200 | 29 | 5 | M9562 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.71e-07 | 198 | 29 | 5 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 157 | 29 | 4 | a9e077f686382303f0437ebfa4f11d273ba9fe40 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-pDC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.65e-06 | 173 | 29 | 4 | b571970e3ba88afc07041c5692ccfd85fc39e796 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 6.60e-06 | 189 | 29 | 4 | 6c2ace61a7d62bcf7e76b73e2da8b722d03e713b | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.17e-06 | 193 | 29 | 4 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.77e-06 | 197 | 29 | 4 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.77e-06 | 197 | 29 | 4 | 8fa38fb95e285f9cc756ec4f32009be4ede09d3c | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 7.93e-06 | 198 | 29 | 4 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 8.09e-06 | 199 | 29 | 4 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | MS-IIF-Myeloid-pDC|IIF / Disease, condition lineage and cell class | 8.09e-06 | 199 | 29 | 4 | e262ee854e64d87460bee810c14d6cbe744460e8 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 8.09e-06 | 199 | 29 | 4 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.25e-06 | 200 | 29 | 4 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | PND01-03-samps-Lymphocyte-B_cell-B_cell_1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.79e-05 | 128 | 29 | 3 | 5d82247ceda55017628720ed8b6c36ff7cec8437 | |
| ToppCell | PND01-03-samps-Lymphocyte-B_cell|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.79e-05 | 128 | 29 | 3 | 7661402dd7cd533c1bfe8d9247cecd88c1be9a5e | |
| ToppCell | PND01-03-samps-Lymphocyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.79e-05 | 128 | 29 | 3 | d3158825a2178244b57ac5ad2676617fd58d8466 | |
| ToppCell | Lymphoid-B_cells|World / shred on cell class and cell subclass (v4) | 1.17e-04 | 147 | 29 | 3 | aa4486200c523f2c9d3bad7a14f1764c2d92076b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 150 | 29 | 3 | cc8361bdcaa16ab6a0d6a3684690d709bc42ff3b | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 151 | 29 | 3 | ee56b88c56c3b6a5ec9644c43cae521ea0e05920 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 151 | 29 | 3 | 2c239b09970acbaa90c5ebe1097f453c516f868e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-04 | 151 | 29 | 3 | 2314c004434aed9b7fa1ad01c61c43e5ed4a18ce | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 156 | 29 | 3 | 44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 156 | 29 | 3 | 55ba43cec9d79f309e9f633a6469cf03bb621e64 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 157 | 29 | 3 | d8e283414a770f05d71f0455d0822e9a9660b115 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 157 | 29 | 3 | 165e98bf944572cafbc06ef43c9eab7bd6bea1c2 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 160 | 29 | 3 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 162 | 29 | 3 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 162 | 29 | 3 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 162 | 29 | 3 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 162 | 29 | 3 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 164 | 29 | 3 | 07d9252b267cb61c6050fbfa5b440aef1349f673 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 164 | 29 | 3 | 7c016236f0cea38195c1373ebbd2c0b2b2ec81ad | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 168 | 29 | 3 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 168 | 29 | 3 | 943687a33fffd7e19d906b9dd385a126bcea109a | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 1.80e-04 | 170 | 29 | 3 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-04 | 171 | 29 | 3 | 656a9f407461dbf5c9c0bd234399e1fef6abce2a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.83e-04 | 171 | 29 | 3 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.83e-04 | 171 | 29 | 3 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 172 | 29 | 3 | 3aed10e6db48254f4cae12fbe52d1a1fc6cf2dce | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 172 | 29 | 3 | 3784fd1e833703519889942e39fda991f03c3c76 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 172 | 29 | 3 | 995139aa38f8b9ff23166128b15476cd8a3ff1b8 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 173 | 29 | 3 | 49030c2dd04b592655df1a667e2f90efb499e0a5 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 173 | 29 | 3 | 1cfbab6603f8baf8e238837bb72740c43a7dc0ec | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 174 | 29 | 3 | 26ca6ebaa0081108d44c01f8ca56a63724f1c99d | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 174 | 29 | 3 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 174 | 29 | 3 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 174 | 29 | 3 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 174 | 29 | 3 | 7c8704766dd4c80250754b5ee9907b342b9c2623 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 174 | 29 | 3 | 9aa2168d3bcef7cdc5a47442618cb8e9eb24c95b | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 1.96e-04 | 175 | 29 | 3 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.96e-04 | 175 | 29 | 3 | 97fe431f224b592b3076632d101e19136c138dcc | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 177 | 29 | 3 | c506b8fd9a550e6cf93b64a1f7eed2543224a140 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 177 | 29 | 3 | 840eaac045ada42cae0ab81177d1d0ae55a65633 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 178 | 29 | 3 | 8d74c12c4b0ce8bcb0f59151bdc67036997095ef | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 178 | 29 | 3 | 8ef229f38aa8a2ae8b366c3ce26d4cb1302d674a | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 178 | 29 | 3 | 525c4b3f9736ff206e2f1378c2a29ba4f13ba22f | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 179 | 29 | 3 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 180 | 29 | 3 | 711719219bcbafdd505790eda895e7a33f21bed2 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-04 | 180 | 29 | 3 | b83d067dee641941c596e4a25d81327931b6ad61 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 180 | 29 | 3 | b51b10781082bc0305ba6a81e978729b329f7771 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | 2c2b812cdd350271935d7007665c26093756ebee | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | 14faef1dde781d501834379f2a6413e8d6a80b72 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | 8855812c85ef45c1be6bd511619b2dfe5e441264 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 181 | 29 | 3 | d909821355f4bc9e35387cda6ecf7c56793d9da4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 181 | 29 | 3 | 52935c496b45207a173b5ac7812f46210c3f74b0 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | 852115eff9a68a6f657aada2386ee4a1e50a4d5b | |
| ToppCell | wk_20-22-Hematologic-Myeloid-pDC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.17e-04 | 181 | 29 | 3 | 60607c5ff6d5b1cb416adc034491dca31c41e988 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | 57f82f54e20e19aa17a2ea22af22e3bc8965d622 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | ce30724788d9b5c6dfa4f9f8d318c3d2565165ed | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 183 | 29 | 3 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 183 | 29 | 3 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 184 | 29 | 3 | eb41dce59eb0384c1671fbc76eb15daab2c8c49a | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-B_cell-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 184 | 29 | 3 | 991500a874c5dd0d9111399520071da67bc6ac3d | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | 1eba3b058e23a7d19024b4363dfeb522a8af313d | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.31e-04 | 185 | 29 | 3 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.35e-04 | 186 | 29 | 3 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.35e-04 | 186 | 29 | 3 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.35e-04 | 186 | 29 | 3 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 187 | 29 | 3 | 57f9c9162694c184a8fd6634ee0fad511ca71c9e | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic-B_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 29 | 3 | 63cc89ce24d3f8fb13479a501a20bfbd798d151a | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-B_cell-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 187 | 29 | 3 | 6ce6d3678026101c4397320430433c9f05740883 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.38e-04 | 187 | 29 | 3 | 160e5f338537d90d50f863a1be801b1071ac7da7 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-B_cell-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.42e-04 | 188 | 29 | 3 | 9526d9e035eadbb0dcd4ad6e79a3a2b7f7845d74 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 188 | 29 | 3 | a7158b5c94e6b356877f016e52f2c24a3f5d24d2 | |
| ToppCell | COVID-19_Severe-pDC|World / disease group, cell group and cell class | 2.42e-04 | 188 | 29 | 3 | 4c8e328b8206120708b05ea3c5865a0200dc5c4e | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.42e-04 | 188 | 29 | 3 | 7c542b226240adcb7797be0ded6523e5732f0078 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 2.46e-04 | 189 | 29 | 3 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 2.50e-04 | 190 | 29 | 3 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 2.50e-04 | 190 | 29 | 3 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 2.50e-04 | 190 | 29 | 3 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 2.50e-04 | 190 | 29 | 3 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-pDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 191 | 29 | 3 | faf4de97003a938a243b0101456913c2b0e1804f | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 2.54e-04 | 191 | 29 | 3 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.54e-04 | 191 | 29 | 3 | 8c487704cbbb5eeff54e8c6fb6fffa1472b5351f | |
| ToppCell | Healthy-pDC|World / disease group, cell group and cell class | 2.54e-04 | 191 | 29 | 3 | 6e1d825dc33b915b95f13ccd237a552160a4be98 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 2.54e-04 | 191 | 29 | 3 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.54e-04 | 191 | 29 | 3 | 78d523f562d32fc408a20d99b0c61cc103241bc0 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 192 | 29 | 3 | 9b8191e66626919cad2c63349c8ef61e9792fcf5 | |
| ToppCell | BLOOD--(3)_DC_(cDC+pDC)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.58e-04 | 192 | 29 | 3 | e290c55a1321e9e577f49e8ba20501b2c8150044 | |
| ToppCell | facs-Diaphragm|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 192 | 29 | 3 | 486cbf9791ca619e307e8b18aa70ce22111f4f26 | |
| Disease | factor VIII measurement, venous thromboembolism | 5.13e-04 | 34 | 29 | 2 | EFO_0004286, EFO_0004630 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 7.84e-04 | 42 | 29 | 2 | EFO_0004286, EFO_0004629 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.80e-03 | 914 | 29 | 5 | EFO_0004532 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.98e-03 | 67 | 29 | 2 | EFO_0004286, EFO_0004623 | |
| Disease | reticulocyte count | 3.23e-03 | 1045 | 29 | 5 | EFO_0007986 | |
| Disease | Glioma | 3.31e-03 | 87 | 29 | 2 | C0017638 | |
| Disease | response to antineoplastic agent | 4.26e-03 | 99 | 29 | 2 | GO_0097327 | |
| Disease | fibrinogen measurement | 5.14e-03 | 109 | 29 | 2 | EFO_0004623 | |
| Disease | Glioblastoma Multiforme | 5.33e-03 | 111 | 29 | 2 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEKWYLMTVVVLIGL | 1 | Q9Y672 | |
| AWMCLEGVQLYLMLV | 926 | O95490 | |
| VLLVILNMMLFYKLW | 636 | Q3KR37 | |
| CVLLIMVMCYLKSQW | 751 | Q99650 | |
| MWSLGVIMYILLCGY | 246 | P49137 | |
| KSCDMWSLGVIMYIL | 221 | Q16644 | |
| WLIAICYPEMVMKLI | 176 | Q8IUS5 | |
| FCYIAIWMGNLLIMI | 31 | Q8NGL7 | |
| WVLMLKYFMCLVVGI | 501 | Q13467 | |
| LVIWICLVAMGYLFM | 111 | Q08462 | |
| MKLGCVLMAWALYLS | 1 | Q7L513 | |
| VWVMIIMVILVLGYG | 261 | Q8IWA5 | |
| TLLVLMLIMVYGFWK | 276 | Q5T2D2 | |
| NIYMGLLIYAMWIIT | 81 | A0A494BZU4 | |
| FMMFFALVVIIKKWS | 201 | Q8IZM9 | |
| IAIFCMLLTYYMWIK | 171 | P46977 | |
| AMLALVLVVMVWYSI | 11 | Q11206 | |
| YEIVMLCGLLKMWED | 341 | Q9BZQ2 | |
| MLYYLGLMQWIIRKV | 301 | Q9HAS3 | |
| MKIAFGNLWMEILYL | 601 | Q5T5J6 | |
| VVMNWAGMRCPYKLL | 326 | O75783 | |
| VFLTLVIFILMKFWM | 431 | P51788 | |
| KWMMFLAVGIYALFV | 136 | Q9H1C4 | |
| YMIVMNWKVCVLLAV | 136 | P0C645 | |
| AICIEEIGIWMKMYS | 306 | Q8N3U4 | |
| CVMMVLLYFFYKWLV | 231 | Q8TCT8 | |
| MVMCIVYILYGILWL | 221 | Q96K49 | |
| MIVLGWMFFVGLVCY | 1 | A0A0U1RRN3 | |
| MRCDIVQKIWMDYLV | 1776 | O60293 | |
| MVMCIVYVLFGVLWL | 231 | Q8NBN3 | |
| WMFEKLVVVMVCYFI | 366 | Q96GC9 |